Pricing Log in Create free account

BGM Group Ltd. (BGM) vs Sofgen Pharma S.A (PROCF)

BGM Group Ltd. and Sofgen Pharma S.A are both Drug Manufacturers Specialty & Generic companies. BGM Group Ltd. and Sofgen Pharma S.A are of similar size ($114.7M and $114.0M). Sofgen Pharma S.A trades at the lower P/E: 0.1× against 144×. Sofgen Pharma S.A has the higher net margin (9.52% vs 1.96%) and the higher return on invested capital (15.2% vs 0.00%). Across the 16 metrics below, Sofgen Pharma S.A leads on 12 and BGM Group Ltd. on 4.

Valuation

Metric BGM PROCF Drug Manufacturers Specialty & Generic median
P/E 144.17 0.07 19.25
P/S n/m 0.01 2.11
P/B n/m n/m 1.78
Price to free cash flow n/m 0.04 16.14
EV/EBITDA n/m 3.32 12.58
EV/Sales (0.09) 0.71 2.73
Earnings yield 0.69% 1,354.00% (4.38%)
Free cash flow yield 0.00% 2,469.89% 0.00%

Profitability

Metric BGM PROCF Drug Manufacturers Specialty & Generic median
Gross margin 6.54% 56.16% 53.94%
Operating margin 0.00% 17.01% 0.00%
Net margin 1.96% 9.52% 0.00%
Free cash flow margin 0.00% 17.66% 0.00%
Return on equity 0.00% (213.06%) (0.40%)
Return on assets 0.00% 8.82% (3.32%)
Return on invested capital 0.00% 15.21% 0.00%

Growth

Metric BGM PROCF Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — 5.10% 10.01%
EPS growth (last fiscal year) 10.00% (270.30%) 49.06%
Revenue growth, 5-year CAGR (5.39%) (1.82%) 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BGM PROCF Drug Manufacturers Specialty & Generic median
Debt to equity 0.00 (435.78) 0.05
Current ratio 1.25 0.64 2.31
Net debt to EBITDA 0.97 (7.21) 0.97

Dividend

Metric BGM PROCF Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.57%
Payout ratio — — 0.27

Size

Metric BGM PROCF Drug Manufacturers Specialty & Generic median
Market cap 114.71m 113.95m 276.90m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack